The Phillies left Spring Training with two players that they drafted in the Rule 5 Draft last December, outfielder Tyler Goeddel and left-handed reliever Daniel Stumpf. After the success of Odubel Herrera last season, the team was hoping to strike lightning again with Goeddel and Stumpf. Unfortunately, they'll have to wait some time before they get to see the 25-year old lefty on the mound again after Major League Baseball suspended him for 80 games for a failed test for performance enhancing drugs. Stumpf tested positive for an anabolic steroid.
The suspension takes place immediately and is without pay, which will cost Stumpf approximately $223,000 of his major league minimum salary of $507,500. Barring any postponed games, Stumpf will be eligible to return to the Phillies roster on July 11.
Stumpf was placed on the Restricted List by the Phillies and another left-hander, Elvis Araujo was recalled from Lehigh Valley to take his roster spot. Players selected in the Rule 5 Draft must remain on the major league roster all season long, but must also have a minimum of 90 days on the active roster, which does not include the Disabled List or Restricted List. Stumpf had accrued 11 days on the active roster and there will be 82 days left in the major league season when he can be reactivated.
In three appearances with the Phillies, Stumpf had made three appearances, giving up a grand slam to Cincinnati's Eugenio Suarez, but then retired the only batter he faced in both of his next two appearances. His ERA stands at 40.50 on the season, with 2/3 of an inning pitched, allowing one hit and two walks, both of which came in his first outing in Cincinnati.
Araujo made the jump from Double-A Reading to Philadelphia last season and was a pleasant surprise out of the bullpen, pitching in 40 games and posting a 3.38 ERA and a 2-1 record with the Phillies. He was optioned to Lehigh Valley late in Spring Training and had pitched in one game, throwing 1 1/3 shutout innings and recording a save for the IronPigs.